NASDAQ · ACLS

Axcelis Technologies Inc.

$115.14 -$18.96 (-14.14%) 1D Market open

Key Metrics

$4.12B
Market cap
40.86×
P/E · TTM
$845.44M
Revenue · TTM
$100.87M
Net income
EPS · TTM $3.12
Dividend yield
Free cash flow $88.48M
Beta · 1Y 2.46
EBITDA · TTM $133.53M
Gross margin 43.6%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 27
    From its Jun 15 high, the share price fell 33%.

    Peak close $191.60 on Jun 15; trough close $128.11 on Jul 27. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -33%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jul 2
    The stock moved -19.0% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jul 2
  • May 6
    The stock moved +22.4% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 6

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$4.12B
Enterprise value
Shares outstanding30.7M
52-wk range$65.64 – $193.78
Avg volume · 20D533.7K
Net cash
Book value / share$32.31
IndustrySpecial Industry Machinery, Nec
ExchangeNASDAQ
About Axcelis Technologies Inc.
IPO dateJul 11, 2000
Employees1465

Axcelis Technologies Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E40.86
P/S4.87
P/FCF46.58
EV/EBITDA
EV/Sales
Graham №$47.62

Profitability

Gross 43.6%
Operating 13.7%
Net 11.9%
FCF 10.5%
ROE / ROIC 9.8% · 14.9%

Financial Health

Current ratio4.59
Quick ratio2.99
Debt / equity
Debt / EBITDA
Net cash
Working capital$731.77M

Cash Flow · TTM

Operating CF $96.65M
Capex −$8.17M
Free cash flow $88.48M
Buybacks $121.08M
Dividends paid
Shareholder yield 2.9%

Piotroski F-Score

3 / 9
Weak fundamentals · 3 of 9 signals passing

Altman Z-Score

9.5
Safe zone (> 2.99) · bankruptcy risk negligible

Graham Number vs Price

$47.62 vs $128.11
Trades 2.7× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings